Home
Scholarly Works
SPECTRUM: early clinical experience from the first...
Conference

SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degeneration

Authors

Bailey C; Lange C; Chaudhary V; Lanzetta P; Oubraham H; Kirchner M; Machewitz T; Allmeier H; Zhang X; Hasanbasic Z

Pagination

pp. 1-4

Publisher

Springer Nature

Publication Date

January 30, 2026

DOI

10.1038/s41433-026-04260-3

Conference proceedings

Eye

ISSN

0950-222X

Contact the Experts team